Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12781715rdf:typepubmed:Citationlld:pubmed
pubmed-article:12781715lifeskim:mentionsumls-concept:C1622968lld:lifeskim
pubmed-article:12781715lifeskim:mentionsumls-concept:C0063700lld:lifeskim
pubmed-article:12781715lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:12781715lifeskim:mentionsumls-concept:C0034987lld:lifeskim
pubmed-article:12781715lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:12781715pubmed:issue2lld:pubmed
pubmed-article:12781715pubmed:dateCreated2003-6-3lld:pubmed
pubmed-article:12781715pubmed:abstractTextWe recently identified a new enhancer element (HIRE-1, HPV-Interferon Responsive Element-1) in the upstream regulatory region (URR) of human papillomavirus (HPV) type 16. HIRE-1 is located upstream from and in close proximity to the TATA box. HIRE-1 is 1 nt shorter in its 5' sequence in comparison to a consensus IRF-1 binding site (IRF-E). Gel shift analyses clearly demonstrated that HIRE-1 is capable of binding IRF-1 in response to interferon-gamma (IFN-gamma) treatment. In a reporter system, HIRE-1 stimulated transcription in response to IRF-1 or IFN gamma from both a heterologous or the homologous (p97) promoter in a dose-dependent manner. Mutations in the core binding sequence strongly decreased this enhancer activity. Interestingly, HIRE-1 stimulated transcription in the context of the full URR in a cell-type-specific manner, thereby suggesting the role of other cell-type-specific factors that might counteract with its function. Thus, our results may explain the inconsistent clinical and experimental results observed following IFN treatment of cervical lesions or cells. Also, this new enhancer may have an important function during inflammatory responses against HPV type 16.lld:pubmed
pubmed-article:12781715pubmed:languageenglld:pubmed
pubmed-article:12781715pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:citationSubsetIMlld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12781715pubmed:statusMEDLINElld:pubmed
pubmed-article:12781715pubmed:monthJunlld:pubmed
pubmed-article:12781715pubmed:issn0042-6822lld:pubmed
pubmed-article:12781715pubmed:authorpubmed-author:WhiteheadWill...lld:pubmed
pubmed-article:12781715pubmed:authorpubmed-author:TyringStephen...lld:pubmed
pubmed-article:12781715pubmed:authorpubmed-author:AranyIstvanIlld:pubmed
pubmed-article:12781715pubmed:authorpubmed-author:GrattendickKe...lld:pubmed
pubmed-article:12781715pubmed:authorpubmed-author:EmberIstvan...lld:pubmed
pubmed-article:12781715pubmed:issnTypePrintlld:pubmed
pubmed-article:12781715pubmed:day5lld:pubmed
pubmed-article:12781715pubmed:volume310lld:pubmed
pubmed-article:12781715pubmed:ownerNLMlld:pubmed
pubmed-article:12781715pubmed:authorsCompleteYlld:pubmed
pubmed-article:12781715pubmed:pagination280-6lld:pubmed
pubmed-article:12781715pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:meshHeadingpubmed-meshheading:12781715...lld:pubmed
pubmed-article:12781715pubmed:year2003lld:pubmed
pubmed-article:12781715pubmed:articleTitleA functional interferon regulatory factor-1 (IRF-1)-binding site in the upstream regulatory region (URR) of human papillomavirus type 16.lld:pubmed
pubmed-article:12781715pubmed:affiliationDepartment of Microbiology, The University of Texas Medical Branch, Galveston, TX 77555-1070, USA. aranyistvan@uams.edulld:pubmed
pubmed-article:12781715pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12781715pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12781715pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12781715lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12781715lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12781715lld:pubmed